On Thursday, December 12, 2019, the stock (BioCryst Pharmaceuticals, Inc.) created a change of 7.25 percent Gain (↑) and closed its last session of business at $2.96. BioCryst Pharmaceuticals, Inc., belongs to Healthcare sector and Biotechnology industry. The relative strength index of the stock stands 63.72. Historical Performance Review: To
Continue readingStill Not Convinced About: – BioCryst Pharmaceuticals, Inc., (NASDAQ: BCRX)
